Healthcare 3/3

top of page

HOME
SOLUTIONS
WHY CHOOSE US
OUR TEAM
CLIENTS
RESEARCH
CONTACT
More

Use tab to navigate through the menu items.

All
ALG Analysts
Newsletter
Edison Insight
TMT
Financials
Mining
Industrials
Consumer
Healthcare
Other

Solid FY22 Marked by Broad-Based Growth

Solid FY22 Marked by Broad-Based Growth

Solid FY22 Marked by Broad-Based Growth

ERGOMED, a services business which includes an industry-leading suite of specialist pharmacovigilance solutions, reported FY22 results...

Jan 18, 20241 min read

Cresemba Expansion Continues with Japan Launch

Cresemba Expansion Continues with Japan Launch

Cresemba Expansion Continues with Japan Launch

Basilea Pharmaceutica has announced that it has received a development-related milestone payment of CHF5m from its Japanese licensing...

Jan 18, 20241 min read

Strong Execution Resulting in Operating Profitability

Strong Execution Resulting in Operating Profitability

Strong Execution Resulting in Operating Profitability

On the heels of management’s January upward guidance revision, continued strong execution of Basilea Pharmaceutica’s outlined strategic...

Jan 18, 20241 min read

Cresemba Milestone Payment Triggered

Cresemba Milestone Payment Triggered

Cresemba Milestone Payment Triggered

Basilea Pharmaceutica has announced that it has received a sales-related milestone payment of CHF20m from its US licensing partner...

Jan 18, 20241 min read

Third Leg of Strategy Executed With Debt Repayment

Third Leg of Strategy Executed With Debt Repayment

Third Leg of Strategy Executed With Debt Repayment

Basilea Pharmaceutica is focused on treating infectious diseases. Basilea has announced the full repayment of the CHF113.8m outstanding...

Jan 18, 20241 min read

All

bottom of page